FIGS.NYSEFigs, INC

Form 4: FIGS Executive Chair's Stock Option Repricing

Sentiment:

Insider Trading Report


FIGS, Inc. Executive Chair Heather Hasson received a significant RSU grant and had millions of stock options repriced to a lower exercise price of $6.63, with new vesting schedules.

Worse than expectedThe repricing of 3,590,925 fully vested stock options to a significantly lower exercise price of $6.63 from original prices of $22.00 and $11.79 effectively provides a new, more favorable incentive to the Executive Chair when the stock price has declined.The re-vesting of these previously vested options over new 24 and 48-month schedules, while ensuring retention, also means the executive benefits from a reset of their equity incentives without necessarily demonstrating new performance beyond what was already compensated.

Summary

  • Heather L. Hasson, Executive Chair, Director, and 10% Owner of FIGS, Inc., reported changes in her beneficial ownership.
  • Acquired 947,868 Restricted Stock Units (RSUs) of Class A Common Stock at a price of $0. These RSUs will vest quarterly over four years, starting August 1, 2025.
  • A total of 3,590,925 fully vested stock options (727,097 at $22.00 and 2,863,828 at $11.79) were repriced.
  • The exercise price for these options was reduced to $6.63 per share, matching the closing price of FIGS Class A Common Stock on August 12, 2025.
  • The repriced options now have new vesting schedules: 727,097 options vest monthly over 24 months, and 2,863,828 options vest monthly over 48 months, both starting September 12, 2025.
  • The expiration dates and the number of shares underlying the repriced options remain unchanged.
  • Hasson directly owns 1,298,197 Class A Common Stock and indirectly holds additional shares through trusts.
  • She also holds 2,814,480 Class B Common Stock and 11,449,396 Class A Common Stock from vested options not reported on this Form 4.

Sentiment

Score: 3

Explanation: The sentiment is moderately negative due to the significant stock option repricing, which benefits the executive at a cost to shareholders, especially given the options were previously vested. While the RSU grant is standard compensation, the repricing event overshadows it from a shareholder perspective.

Positives

  • The grant of 947,868 Restricted Stock Units (RSUs) at a $0 price represents significant long-term incentive compensation for the Executive Chair.
  • The stock option repricing to $6.63 per share significantly reduces the exercise price for 3,590,925 options, potentially increasing their intrinsic value for the Executive Chair.
  • The new vesting schedules for the repriced options (24 and 48 months) align the Executive Chair's incentives with the company's long-term performance and retention.

Negatives

  • The repricing of fully vested stock options to a lower exercise price of $6.63, especially from higher prices like $22.00 and $11.79, can be viewed negatively by shareholders as it effectively re-grants options at a lower strike price, potentially diluting shareholder value or signaling management's lack of confidence in the stock's recovery to previous highs.
  • Resetting the vesting schedules for previously vested options means the Executive Chair receives new incentives despite the options already being exercisable, which might be perceived as overly favorable compensation.

Future Outlook

NA

Industry Context

This filing reflects a common practice in the apparel and healthcare apparel industry where executive compensation packages are adjusted, often through equity grants and repricings, to align with company performance and market conditions, especially during periods of stock price volatility. Repricing can be a tool for executive retention when stock prices have declined significantly.

Comparison to Industry Standards

  • Stock option repricing, while controversial, is not uncommon across industries, particularly in growth-oriented companies or those experiencing significant stock price declines. Companies like Peloton (PTON) and Beyond Meat (BYND) have faced similar situations where executive equity incentives were adjusted following substantial share price drops.
  • The grant of Restricted Stock Units (RSUs) with a multi-year vesting schedule is a standard compensation practice aimed at long-term executive retention and alignment with shareholder interests, comparable to practices at companies such as Lululemon (LULU) or Nike (NKE) in the broader apparel sector.
  • The specific terms of the repricing, reducing the exercise price to the current market price, are aggressive but not unprecedented, aiming to restore the incentive value of the options for the executive.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Policy AdjustmentThe company implemented a one-time stock option repricing for executive Heather Hasson, reducing the exercise price of 3,590,925 previously vested options to $6.63 and extending their vesting schedules.08/12/2025This change impacts executive compensation structure, potentially improving executive retention and motivation by restoring incentive value to underwater options, but may be viewed as dilutive or overly favorable to management by shareholders.

Related Party Transactions

  • Heather Hasson, as a managing member of Hollywood Capital Partners LLC, disclaims beneficial ownership of 141 Class A Common Stock held by the LLC, except to the extent of her pecuniary interest therein.

Stakeholder Impact

  • Shareholders: Potential negative impact due to the repricing of stock options, which can be perceived as dilutive or a transfer of value from shareholders to management, especially for previously vested options. The RSU grant represents standard compensation.
  • Employees: No direct impact on general employees mentioned, but executive compensation practices can influence overall company morale and perception of fairness.
  • Management/Executives: Significant positive impact for Heather Hasson, as the repricing makes her stock options more valuable and the RSU grant provides additional long-term equity incentive, enhancing retention.

Next Steps

  • Continued vesting of 947,868 Restricted Stock Units (RSUs) on a quarterly basis following August 1, 2025.
  • Continued vesting of 727,097 repriced stock options monthly over 24 months, starting September 12, 2025.
  • Continued vesting of 2,863,828 repriced stock options monthly over 48 months, starting September 12, 2025.
  • Further details regarding the Option Repricing are available in the Issuer's Form 10-Q filed with the SEC on August 7, 2025.

Key Dates

DateDescription
05/26/2021Original grant date for 727,097 stock options with an exercise price of $22.00.
08/09/2022Original grant date for 2,863,828 stock options with an exercise price of $11.79.
08/07/2025Date of Issuer's Form 10-Q filing with the SEC, referenced for more information on the Option Repricing.
08/12/2025Date of earliest transaction, effective date of the stock option repricing, and date of RSU acquisition.
09/12/2025First installment vesting date for the repriced stock options.
05/25/2031Expiration date for 727,097 repriced stock options.
08/08/2032Expiration date for 2,863,828 repriced stock options.

Recommendation

hold

The stock option repricing for a key executive, particularly involving previously vested options, is generally viewed unfavorably by investors as it can signal a lack of confidence in the stock's recovery or an overly generous compensation practice. However, this Form 4 does not provide details on the company's financial performance or strategic outlook, which are crucial for a definitive buy or sell recommendation. The RSU grant is a standard compensation tool for retention. Therefore, a 'hold' recommendation is appropriate until more comprehensive financial and operational data is available to assess the company's overall health and prospects.

Keywords

FIGS Inc., FIGS, Heather Hasson, SEC Form 4, Stock Option Repricing, Restricted Stock Units, Executive Compensation, Insider Trading, Corporate Governance, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.